Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Morgan Stanley Investment Funds - Us Advantage Fund Z (0P0000JM6Q)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
117.920 +2.870    +2.49%
26/04 - Closed. Currency in USD ( Disclaimer )
Type:  Fund
Market:  Luxembourg
Issuer:  Morgan Stanley Investment Management (ACD) Limited
ISIN:  LU0360484686 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 3.92B
Morgan Stanley Investment Funds US Advantage Fund 117.920 +2.870 +2.49%

Morgan Stanley Investment Funds - Us Advantage Fund Z Overview

 
On this page you'll find an in-depth profile of Morgan Stanley Investment Funds - Us Advantage Fund Z. Learn about the key management, total assets, investment strategy and contact information of 0P0000JM6Q among other information.
Category

US Large-Cap Growth Equity

Total Assets

3.92B

Expenses

0.85%

Inception Date

Sep 05, 2008

Investment Strategy

The Fund’s investment objective is to seek long-term capital appreciation, measured in US Dollars, by investing primarily in securities issued by US companies and on an ancillary basis in securities issued by companies that are not from the US. An issuer may be considered to be from a particular country (including the US) or geographic region if (i) its principal securities trading market is in that country or geographic region; (ii) alone or on a consolidated basis it derives 50% or more of its annual revenue from goods produced, sales made or services performed in that country or geographic region; or (iii) it is organized under the laws of, or has a principal office in, that country or geographic region. By applying these tests, it is possible that a particular issuer could be deemed to be from more than one country or geographic region.

Contact Information

Address The Observatory, 7-11 Sir John Rogerson’s Quay, Dublin 2
Dublin,
Ireland
Phone -

Top Executives

Name Title Since Until
Alexander T. Norton Senior Investor 2009 Now
Biography Alexander Norton is an investor for the Counterpoint Global team. He joined Morgan Stanley in 2000 and has been with financial industry since 1995. Prior to joining the firm, Alex was an associate in equity derivative sales and later an associate in equity research at Donaldson, Lufkin & Jenrette. Previously, he was a bond broker with Cantor Fitzgerald. Alex received a B.A. in history from the University of Pennsylvania and an M.B.A. in finance from Columbia Business School.
Jason C. Yeung Managing Director 2009 Now
Biography Jason Yeung is an investor for the Counterpoint Global team. He joined Morgan Stanley in 2002 and has been with financial industry since 1997. Jason joined the team in 2004 as an investor. Previously, he was a member of the U.S. Research Group, working closely with the Counterpoint Global team. Prior to joining the firm, Jason was a senior research analyst at Ramius Capital Group. Previously, he was an equity research associate at Deutsche Bank. Jason received a B.A., Phi Beta Kappa, in international relations from Johns Hopkins University and an M. Phil. in international relations from the University of Cambridge. He holds the Chartered Financial Analyst designation.
Armistead B. Nash Executive Director 2009 Now
Biography Armistead Nash is an investor for the Counterpoint Global team. He joined Morgan Stanley in 2002 and has has been with financial industry since 2000. Armistead joined the team in 2004 as an investor. Previously, he was a member of the U.S. Research Group, working closely with the Counterpoint Global team. Prior to joining the firm, Armistead was an associate in investment product development at BlackRock Financial Management. Previously, he was a research analyst in high-yield research at KEA Capital. Armistead received a B.A. in history from the University of Virginia and an M.B.A. from the University of Virginia's Darden School of Business Administration.
Dennis P. Lynch Team Leader 2009 Now
Biography Dennis is the Head of the Counterpoint Global team at Morgan Stanley Investment Management. He joined Morgan Stanley in 1998 and has been with financial industry since 1994. Prior to joining the firm, he worked as a sell-side analyst for J.P. Morgan Securities. Dennis received a B.A. in political science from Hamilton College and an M.B.A. with honors in finance from Columbia University.
David S. Cohen Senior Investor 2009 Now
Biography Dave Cohen is an investor for the Counterpoint Global team. He joined Morgan Stanley in 1993 and has has been with financial industry since 1988. Dave joined the team as an investor in 1999. Prior to joining the firm, Dave was a senior fund accountant at Alliance Capital. Previously, he was a fund accountant at Natwest and Wall Street Trust. Dave received a B.S. summa cum laude in management from Pace University.
Sandeep (Sam) G. Chainani Senior Investor 2009 Now
Biography Sam Chainani is an investor for the Counterpoint Global team. He joined Morgan Stanley in 1996 and has been with financial industry since 1996. Sam joined the team as an investor in 2000. Previously, he was a strategy specialist for our Inception and Discovery strategies. Sam received a B.S. in management with a concentration in finance from Binghamton University. He holds the Chartered Financial Analyst designation.
Paras C. Dodhia Partner 2005 2009
Biography Paras is a partner and portfolio manager at Independent Franchise Partners, LLP. Paras' investment experience began in 2000. Prior to founding the Firm in June 2009, Paras was Executive Director and a portfolio manager/ research analyst for Global and American Franchise portfolios at Morgan Stanley Investment Management, which he joined in July 2002. Previously, Paras was an equity analyst at JPMorgan Chase and a strategy consultant for Oliver Wyman & Co. Paras received a B.Sc. in Management from the London School of Economics and an M. Phil. in Finance from the University of Cambridge. He is a CFA® Charterholder.
Michael Allison Partner & Co-Lead Investor 2005 2009
Biography Michael Allison, CFA is Co-Lead Investor, with 26 years of experience and 18 years of managing Franchise portfolios. From 2000-2009, Allison was at Morgan Stanley, and previously at NatWest Markets and Unilever. Allison has a B.Comm and Post Graduate Diploma in Management Accounting (University of Natal) and is a CFA® Charterholder and Chartered Global Management Accountant (CGMA).
Hassan Elmasry Lead Portfolio Manager 2005 2009
Biography Hassan is non-executive chair at Independent Franchise Partners, LLP. He has 39 years of investment experience and was previously the Firm’s managing partner and lead investor. Prior to founding the Firm in June 2009, Hassan was a Managing Director and Lead Portfolio Manager at Morgan Stanley Investment Management. Hassan joined Morgan Stanley in 1995 and was responsible for European equity portfolios until assuming responsibility for Global Franchise in April 2002. Hassan stepped away from the Franchise Partners investment team in June 2022, and retired from his day-to-day duties at the Firm
Jayson Vowles Associate 2005 2009
Biography Jayson Vowles, CFA is Co-Lead Investor with 21 years of experience and 19 years of managing Franchise portfolios. From 2003-2009, Vowles was at Morgan Stanley, and previously at Goldman Sachs and Deloitte & Touche. Vowles has a B.Comm and Post Graduate Diploma in Accounting (University of Natal) and is a CFA® Charterholder and Qualified Chartered Accountant (South African Institute of Chartered Accountants).
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000JM6Q Comments

Write your thoughts about Morgan Stanley Investment Funds - Us Advantage Fund Z
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
WIWAT WONGPONGSAWIWAT
WIWAT WONGPONGSAWIWAT Mar 21, 2022 11:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
KUSARMF
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email